Paid Clinical Trials in Harrisburg, PA
As of August 2026, 60 paid clinical trials are recruiting in Harrisburg, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Harrisburg offers studies at sites including UPMC Pinnacle Cancer Center/Community Osteopathic Campus for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Head and Neck Squamous Cell Carcinoma, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Harrisburg
Trials by drug in Harrisburg
Filter results
56 clinical trials
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Global Paradise System US Post Approval Study
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Prevail Global Study
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Prospective Study to Assess a Diagnostic Aid for Cancer
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
EFS of the DUO System for Tricuspid Regurgitation
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot Study
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
E-Mindfulness Approaches for Living After Breast Cancer
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Top Research Study Locations in Harrisburg
Researchers run research studies in Harrisburg, PA at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UPMC Pinnacle Cancer Center/Community Osteopathic Campus | Anatomic Stage II Breast Cancer AJCC v8, Head and Neck Squamous Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 28 |
| Susquehanna Research Group | Ankylosing Spondylitis, Autoimmune Diseases, Birdshot Chorioretinitis | 4 |
| Pennsylvania Psychiatric Institute | Anxiety, Chemically-Induced Disorders, Chronic Stress | 2 |
| Pinnacle Health Cardiovascular Institute | Heart Failure | 2 |
| Susquehanna Research Group, LLC | Celiac Disease, Moderately to Severely Active Crohn Disease | 2 |
| UPMC Harrisburg | Cardiovascular Diseases, Hypertension, Pulmonary Embolism | 2 |
| UPMC Pinnacle Harrisburg | Heart Valve Diseases, Previously Treated Non-Small Cell Lung Cancer, Tricuspid Regurgitation | 2 |
| UPMC Pinnacle Harrisburg Campus | Coronary Artery Disease, Mitral Valve Regurgitation | 2 |
| Investigational | Crohn's Disease, Ulcerative Colitis | 2 |
| GSK Investigational Site | Irritable Bowel Syndrome | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Parents and Children Together (PACT) Lab Space | Anxiety Symptoms, Conduct Problems, Depressive Symptoms | 1 |
| Penn State Health Medical Group - Andrews Patel | Breast Cancer | 1 |
| Penn State Health Medical Group - Andrews Patel Hematology/Oncology East | Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma | 1 |
| Penn State Hershey Medical Center-TLC Research and Treatment Center | Problematic Sexual Behavior Among Preteen Children | 1 |
| PennState Hershey Medical Center--PennState Health Children's Hospital | Hypoplastic Left Heart Syndrome (HLHS) | 1 |
| Susquehanna Research Group - Gastroenterology | C. Diff Infection, C.Difficile Diarrhea, CDI | 1 |
| Susquehanna Valley Pain Management | Lumbar Spinal Stenosis | 1 |
| UPMC Heart & Vascular Institute | Mitral Valve Insufficiency | 1 |
| UPMC Hillman Cancer Center - Pinnacle (Community Osteopathic / Medical Sciences Pavillion) | Colorectal Neoplasms | 1 |
| UPMC Pinnacle | Tricuspid Regurgitation, Tricuspid Valve Disease | 1 |
| Univ of Pittsburg Med Ctr Pinnacle | Early Breast Cancer | 1 |
| University of Pittsburg Medical Center - Harrisburg | Distal Femur Fracture | 1 |
| University of Pittsburgh Medical Center | Kidney Transplant Rejection | 1 |
Active & Upcoming Studies in Harrisburg (2026)
Recruiting trials in Harrisburg grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (32 active studies)
- A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · Phase 3 · National Cancer Institute (NCI)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
Cardiovascular (6 active studies)
- Alleviant ALLAY-HFrEF Study · Alleviant Medical, Inc.
- Prevail Global Study · Medtronic Vascular
Mental health & behavior (4 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Video-feedback Intervention to Promote Racial-Ethnic Socialization Competency (VIP-RACE) · Penn State University
Neurology & pain (1 active study)
Pediatric (1 active study)
- Treatment for Problematic Sexual Behavior of Preteen Children · Milton S. Hershey Medical Center
Common conditions studied in Harrisburg
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Breast Cancer (3 active studies)
- Head and Neck Squamous Cell Carcinoma (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
- Celiac Disease (2 active studies)
Leading research sponsors in Harrisburg
- NRG Oncology
- National Cancer Institute (NCI)
- ECOG-ACRIN Cancer Research Group
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Harrisburg?
There are approximately 60 recruiting clinical trials in Harrisburg, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Harrisburg pay participants?
Most recruiting trials in Harrisburg compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Harrisburg?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Harrisburg?
The most common conditions under active study in Harrisburg include Anatomic Stage II Breast Cancer AJCC v8 (3), Breast Cancer (3), Head and Neck Squamous Cell Carcinoma (3), Stage IV Lung Cancer AJCC v8 (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Harrisburg?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Harrisburg on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Harrisburg?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Harrisburg?
Recruiting research sites in Harrisburg include UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Susquehanna Research Group, Pennsylvania Psychiatric Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Harrisburg right now?
The largest active categories in Harrisburg are Cancer & tumors (32), Cardiovascular (6), Mental health & behavior (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.